Breaking News
July 15, 2018 - Parents who had severe trauma, stresses in childhood more likely to have kids with behavioral health problems
July 15, 2018 - At colloquium, a range of views on value of predictive algorithms | News Center
July 15, 2018 - Pittcon invites oral and poster presentations for 2019 Technical Program
July 15, 2018 - Virtual reality could offer psychotherapy for fear of heights, study shows
July 15, 2018 - Retooled vaccine raises hopes as a lower-cost treatment for Type 1 diabetes
July 15, 2018 - Kolon TissueGene To Start US Phase III Clinical Trial For Invossa
July 15, 2018 - Study finds prenatal marijuana use can affect infant size, behavior
July 15, 2018 - Howard Chang named HHMI investigator | News Center
July 15, 2018 - Study shows tailored mental health services improve wellbeing of emerging adults
July 15, 2018 - A bright future might help teens steer clear of violence
July 15, 2018 - Stanford Medicine magazine explores the art, science of listening and hearing | News Center
July 15, 2018 - New study tracks how the brain turns simple sensory inputs into meaningful categories
July 15, 2018 - Deadlier subtype of metastatic prostate cancer found to be common than previously thought
July 15, 2018 - UZH scientists identify enzyme that controls cell division
July 15, 2018 - Unhealthy Food Behaviors May Signal Eating Disorder in Teen
July 15, 2018 - Study raises doubts on a previous theory of Parkinson’s disease
July 15, 2018 - Grant awarded to study whether stem cells can treat urinary incontinence | News Center
July 15, 2018 - Imaging techniques may help assess immune system recovery in HIV patients
July 15, 2018 - Machine-learning may aid in diagnosis and treatment of mental health disorders
July 15, 2018 - ‘Skin Cancer, Take A Hike!’ program promotes sun safety and skin cancer awareness
July 15, 2018 - Blink Health announces lowest prices for generic prescriptions through Blue Eagle Health
July 15, 2018 - New drug strategy can alleviate multiple behavioral, cellular deficiencies in FXS mouse model
July 15, 2018 - Georgia State professor receives federal grant to study virus similar to Ebola virus
July 15, 2018 - Quitting Smoking? Even a Little Exercise Can Help You Stay Slim
July 15, 2018 - DBS treatment may slow the progression of Parkinson’s tremor in early-stage patients
July 15, 2018 - 5 Questions: Luby on virus with potential to cause global pandemic | News Center
July 15, 2018 - Corn loses its cancer-fighting phenolic acids when processed into cornflakes
July 15, 2018 - Study uncovers possible link between iron loading, alcohol intake and mortality
July 15, 2018 - Molecular insights of NagA enzyme could help combat TB
July 15, 2018 - The Facts on Tampons—and How to Use Them Safely
July 15, 2018 - Normalisation of ‘plus-size’ risks hidden danger of obesity, study finds
July 15, 2018 - $2.5 million award to support physician-scientist training | News Center
July 15, 2018 - Aeras announces publication of Phase 2 results of two TB vaccines
July 15, 2018 - Public to set research priorities in field of ethnic inequalities and severe mental illness
July 15, 2018 - Eisai and Biogen Announce Positive Topline Results of the Final Analysis for BAN2401 at 18 Months
July 15, 2018 - U.S. obesity rates rising again
July 15, 2018 - Millions could have incorrect statin, aspirin and blood pressure prescriptions | News Center
July 15, 2018 - Researchers identify factors associated with cell phone-related distracted driving in parents
July 15, 2018 - Bioethicists suggest ethical considerations for forensic use of genetic data
July 15, 2018 - Most clinical trial participants find benefits of sharing personal data outweigh risks, Stanford study finds | News Center
July 14, 2018 - Researchers solve protein puzzle that paves way for new cancer therapies
July 14, 2018 - Blood telomeres can help predict risk of disease worsening or death in COPD patients
July 14, 2018 - CDC: Nearly One-Third of Injury Deaths Occur at Home
July 14, 2018 - Injectable electronics offer powerful new tool in understanding how retinal cells work
July 14, 2018 - Human blood cells transformed into functional neurons | News Center
July 14, 2018 - Podcast: KHN’s ‘What the Health?’ ACA under fire. Again.
July 14, 2018 - Small device with motion sensors can predict older adults’ risk of falling
July 14, 2018 - Neurological Fallout From Ebola Infection Worse Than Thought
July 14, 2018 - Screening for impaired vision in older adults: New Canadian guideline
July 14, 2018 - Blood test for pregnant women can predict premature birth, Stanford-led study reports | News Center
July 14, 2018 - Study uncovers process that neutralizes tumor cells
July 14, 2018 - Four-protein biomarker blood test improves lung cancer risk assessment for smokers
July 14, 2018 - Researchers develop novel approach to bridge gap in cell-free systems
July 14, 2018 - Research reveals new gears in the circadian clock
July 14, 2018 - Researchers assess role of physician in preventing intimate partner violence perpetration
July 14, 2018 - Two diabetes medications don’t slow progression of type 2 diabetes in youth
July 14, 2018 - New clues to restoring fertility in women with disabling ovary disorder
July 14, 2018 - Compound in citrus oil could reduce dry mouth in head, neck cancer patients | News Center
July 14, 2018 - Streck ARM-D Kits detect more antibiotic resistance than comparable tests
July 14, 2018 - Study finds wide variations in follow-up imaging for women with non-metastatic breast cancer
July 14, 2018 - FDA expands its support for states to implement FSMA Produce Safety Rule
July 14, 2018 - CTI BioPharma Announces the Continuation without Modification of PAC203 Phase 2 Study of Pacritinib in Patients with Myelofibrosis Previously Treated with Ruxolitinib
July 14, 2018 - First-hand accounts of premature baby loss inspires new resource
July 14, 2018 - Study identifies cellular ‘death code’ | News Center
July 14, 2018 - Federal judge enters consent decree against Minnesota dairy farm for selling adulterated meat
July 14, 2018 - New web-based game motivates people to exercise more
July 14, 2018 - Calcium electrotransfer could be used to target cancer cells, study finds
July 14, 2018 - Researchers identify new region in mouse brain that affects appetite and body weight
July 14, 2018 - Repeated testing produces ‘practice effect’ that obscures true cognitive decline
July 14, 2018 - Amgen And UCB Resubmit Biologics License Application (BLA) For Evenity (romosozumab) To The US FDA
July 14, 2018 - New research detects brain cell that improves learning
July 14, 2018 - Spirit, Inspiring Change award winners announced | News Center
July 14, 2018 - Opioid patients face several barriers to treatment, study finds
July 14, 2018 - Black adults more likely to develop high blood pressure by age of 55
July 14, 2018 - Insurers fall short in catching and reporting Medicaid fraud, inspectors find
July 14, 2018 - Scientists identify structural and functional differences in human immune-surveillance protein
July 14, 2018 - FDA Approves TPOXX (tecovirimat) as the First Drug for the Treatment of Smallpox
July 14, 2018 - Visual perceptual skills are updated by process similar to memory reconsolidation, study finds
July 14, 2018 - Big Data in Precision Health focuses on how to make technology work for patient care | News Center
July 14, 2018 - New technique measures how well cancer drugs reach their targets
Scientists discover the molecular trigger of necroptosis

Scientists discover the molecular trigger of necroptosis

image_pdfDownload PDFimage_print

Researchers in Australia have uncovered a trigger for an immune-related cell death pathway called necroptosis. It is hoped that the discovery may provide new targets for the treatment of a range of disorders, including immune disorders and several types of cancer.

Image Credit: Juan Gaertner / Shutterstock

Necroptosis is a form of programmed cell death occurring in vertebrate cells. It is actioned by immune cells, which rupture cellular membranes to release the intracellular components.

Necroptosis is involved in the regulation of normal embryonic development, T-cell proliferation, and chronic intestinal inflammation as well as being used in response to infection by pathogens that inhibit classic apoptosis.

Excessive or inappropriate activation of necroptosis is thought to occur in a variety of diseases and conditions, including stroke, organ transplant injury and kidney disease, immune disorders and cancer.

Some currently available anti-cancer drugs, called BH3-mimetics, target defects that prevent cells from undergoing programmed cell death. It is hoped that further elucidation of the pathways involved will enable the development of novel anti-cancer treatments.

A key protein in the initiation of necroptosis is the pseudokinase mixed lineage kinase domain-like (MLKL). It has been well studied in several model systems and is known to be activated by phosphorylation by the protein kinase RIPK3.

For the first time, necroptosis and MLKL activation has been studied in human cells to investigate the role it plays in the development of cancer.

A research team from the Walter and Eliza Hall Institute in Melbourne assessed the effect of several MLKL mutations found in human cancers on cell death by necroptosis.

We found that most of the mutations in MLKL in human cancers delayed cell death by necroptosis”.

James Murphy, Associate Professor

The team also discovered that the necroptosis pathway in humans has a number of crucial differences from the models used in previous research of programmed cell death.

MLKL is always present in human cells but is tightly controlled so it remains inactive until a problem is detected, and only then will it signal to the immune system to kill a cell. It is beneficial to cancer cells to inhibit this process in order to ensure survival.

Delaying necroptosis may be advantageous to cancer cells, or cells that are pre-cancerous, either by allowing them more time to turn into cancer, making them less responsive to cancer therapies, or not alerting the immune system so quickly to their existence.”

James Murphy, Associate Professor

For the first time, the dormant MLKL and activation of the protein through its binding to RIPK3 have been visualised in human cells.

This is the first time that we have been able to visualise how the MLKL protein works in human cells. We showed that human MLKL differs in some critical ways from our model systems, which has significant implications for any attempts to target this pathway to treat disease.”

Dr Emma Petrie, Co-Author

Although the team have identified the molecular trigger for initiating necroptosis in human cells and demonstrated its role in cancer development, further research is needed to identify additional checkpoints that ensure the very tight regulation of MLKL inhuman cells.

Importantly, identification of the molecular pathway triggering necroptosis in human cells has provided novel potential therapeutic targets for the development of new treatments for a range of disorders and cancer.

Source:

Walter and Eliza Hall Institute press release 21 June 2108.

Tagged with:

About author

Related Articles